Our results demonstrate that Rad52 depletion increased cell death, decreased myeloid cell frequency, and augmented the incidence and activity of CD8+ T cells and NK effectors that ultimately led to reduced tumor growth. This evidence concerns the gene RAD52 and neoplasm.